Related Experiment Video
Updated: Sep 28, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation
Marc Pouliot1, Marie-Elaine Fiset, Mireille Massé
1Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du Centre Hospitalier Universitaire de Québec, and Faculté de Médecine, Université Laval, Canada. Marc.Pouliot@crchul.ulaval.ca
Abstract:
Polymorphonuclear neutrophils (granulocytes; PMNs) are often the first blood cells to migrate toward inflammatory lesions to perform host defense functions. PMNs respond to specific stimuli by releasing several factors and generate lipid mediators of inflammation from the 5-lipoxygenase and the inducible cyclooxygenase (COX)-2 pathways. In view of adenosine's anti-inflammatory properties and suppressive impact on the 5-lipoxygenase pathway, we addressed in this study the impact of this autacoid on the COX-2 pathway. We observed that adenosine up-regulates the expression of the COX-2 enzyme and mRNA. Production of PGE(2) in response to exogenous arachidonic acid was also increased by adenosine and correlated with COX-2 protein levels. The potentiating effect of adenosine on COX-2 could be mimicked by pharmacological increases of intracellular cAMP levels, involving the latter as a putative second messenger for the up-regulation of COX-2 by adenosine. Specific COX-2 inhibitors were used to confirm the predominant role of the COX-2 isoform in the formation of prostanoids by stimulated PMNs. Withdrawal of extracellular adenosine strikingly emphasized the inhibitory potential of PGE(2) on leukotriene B(4) formation and involved the EP(2) receptor subtype in this process. Thus, adenosine may promote a self-limiting regulatory process through the increase of PGE(2) generation, which may result in the inhibition of PMN functions. This study identifies a new aspect of the anti-inflammatory properties of adenosine in leukocytes, introducing the concept that this autacoid may exert its immunomodulatory activities in part by modifying the balance of lipid mediators generated by PMNs.
Insights
Adenosine enhances cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) production in polymorphonuclear neutrophils (PMNs). This suggests adenosine may limit inflammation by boosting PGE2, which inhibits PMN functions.
Area of Science:
- Immunology
- Biochemistry
Background:
- Polymorphonuclear neutrophils (PMNs) are key immune cells migrating to inflammatory sites.
- PMNs produce lipid mediators via 5-lipoxygenase and cyclooxygenase-2 (COX-2) pathways.
- Adenosine is known for anti-inflammatory effects, particularly on the 5-lipoxygenase pathway.
Purpose of the Study:
- To investigate the impact of adenosine on the COX-2 pathway in PMNs.
- To elucidate adenosine's role in regulating inflammatory mediator production.
Main Methods:
- Studied adenosine's effect on COX-2 enzyme and mRNA expression.
- Measured prostaglandin E2 (PGE2) production in response to arachidonic acid.
- Utilized pharmacological agents to mimic adenosine's effects and COX-2 inhibitors.
- Investigated the role of EP(2) receptors in adenosine's regulatory effects.
Main Results:
- Adenosine up-regulates COX-2 expression and mRNA in PMNs.
- Adenosine increases PGE2 production, correlating with COX-2 levels.
- Increased intracellular cAMP levels mimic adenosine's COX-2 up-regulation.
- PGE2, via EP(2) receptors, inhibits leukotriene B4 formation when extracellular adenosine is withdrawn.
Conclusions:
- Adenosine enhances COX-2 mediated PGE2 generation in PMNs.
- Adenosine may promote self-limiting inflammation by increasing PGE2.
- This study reveals a novel immunomodulatory mechanism of adenosine in leukocytes via lipid mediator balance.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
cAMP-dependent Protein Kinase Pathways
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...

